Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Current Deferred Tax Assets: 2020

Historic Current Deferred Tax Assets for Terns Pharmaceuticals (TERN) over the last 1 years, with Dec 2020 value amounting to $2.1 million.

  • Terns Pharmaceuticals' Current Deferred Tax Assets was N/A to $2.1 million in Q4 2020 from the same period last year, while for Dec 2020 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2020, which is N/A change from last year.
  • As of FY2020, Terns Pharmaceuticals' Current Deferred Tax Assets stood at $2.1 million.
  • Terns Pharmaceuticals' 5-year Current Deferred Tax Assets high stood at $2.1 million for FY2020, and its period low was $2.1 million during FY2020.
  • Its 1-year average for Current Deferred Tax Assets is $2.1 million, with a median of $2.1 million in 2020.